MicroStrategy may enter the Nasdaq 100 this week
MicroStrategy is on the verge of potentially joining the Nasdaq 100, possibly replacing Moderna, due to a remarkable surge in its stock driven by substantial investments in Bitcoin. Analysts Eric Balchunas and James Seyffart anticipate that this inclusion could be announced as early as this Friday, with an official listing expected on December 23. This would represent a significant achievement for MicroStrategy, positioning it among the top 100 publicly traded